Danaher Corporation (NYSE:DHR) Q2 2024 Earnings Conference Call July 23, 2024 8:00 AM ET Company Participants John Bedford - VP of IR Rainer M. Blair - President & CEO Matt McGrew - EVP & CFO Conference Call Participants Jack Meehan - Nephron Research Rachel Vatnsdal - J.P. Morgan Scott Davis - Melius Research Vijay Kumar - Evercore ISI Michael Ryskin - Bank of America Securities Daniel Brennan - TD Cowen Douglas Schenkel - Wolfe Research Tycho Peterson - Jefferies Operator Good morning. My name is Todd, an ...

Danaher (DHR) came out with quarterly earnings of $1.72 per share, beating the Zacks Consensus Estimate of $1.57 per share. This compares to earnings of $2.05 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 9.55%. A quarter ago, it was expected that this industrial and medical device maker would post earnings of $1.72 per share when it actually produced earnings of $1.92, delivering a surprise of 11.63%.Over the last four quar ...

Danaher Corporation Second Quarter 2024 Earnings Release July 23, 2024 Forward Looking Statements Statements in this presentation that are not strictly historical, including any statements regarding events or developments that we believe or anticipate will or may occur in the future are "forwardlooking" statements within the meaning of the federal securities laws. There are a number of important factors that could cause actual results, developments and business decisions to differ materially from those sugg ...

WASHINGTON, July 23, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended June 28, 2024.  All results in this release reflect only continuing operations unless otherwise noted.Key Second Quarter 2024 ResultsNet earnings were $907 million, or $1.22 per diluted common share and non-GAAP adjusted diluted net earnings per common share were $1.72.Revenues decreased 3.0% year-over-year to $5.7 billion and non-GAAP core revenue decreased 3.5%.Operating ...

Exhibit 99.1 Innovation at the speed of life Danaher Reports Second Quarter 2024 Results WASHINGTON D.C., July 23, 2024 -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended June 28, 2024. All results in this release reflect only continuing operations unless otherwise noted. Key Second Quarter 2024 Results • Net earnings were $907 million, or $1.22 per diluted common share and non-GAAP adjusted diluted net earnings per common share were $1.72. • Revenues decreased ...

Sundry Photography I last covered Danaher Corporation (NYSE:DHR) in April, discussing the company's good medium to long-term prospects. While the stock experienced a high single-digit percentage increase from my article until mid-June, it has since given up most of its gains and is now trading at the same level as when the previous article was published. The company is due to report its earnings on 23rd July before the market opens. If we go by commentary from some of the company's peers in the bioprocessin ...

Danaher Corporation (DHR) is scheduled to release second-quarter 2024 results on Jul 23, before market open.The company’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 8.6%. In the last reported quarter, its earnings of $1.92 per share beat the consensus estimate of $1.72 by 11.6%.Let’s see how things have shaped up for Danaher this earnings season.Key Factors and Estimates for Q2Strength in the molecular diagnostics business, driven by inc ...

DH Diagnostics LLC Centers aim to accelerate drug development by speeding and streamlining development and commercialization of companion diagnostics.Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP)-certified laboratories will bring technologies and assays from multiple Danaher subsidiaries together under a single roof.WASHINGTON, July 17, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher"), a global science and technology innovator, announced the lau ...

Danaher (DHR) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Individual investors o ...

Investors interested in Conglomerates stocks should always be looking to find the best-performing companies in the group. Has Danaher (DHR) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.Danaher is one of 24 individual stocks in the Conglomerates sector. Collectively, these companies sit at #1 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Ra ...